Gastroparesis: Symptoms, Evaluation, and Treatment

Gastroenterology Clinics of North America

Volumn 36, Issue 3, 2007, Pages 619-647

  Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETHANECHOL; BOTULINUM TOXIN; BUSPIRONE; CISAPRIDE; CLARITHROMYCIN; DIMENHYDRINATE; DOMPERIDONE; ERYTHROMYCIN; MECLOZINE; METOCLOPRAMIDE; MIRTAZAPINE; NITRATE; PHYSOSTIGMINE; PROCHLORPERAZINE; PYRIDOSTIGMINE; SCOPOLAMINE; SUMATRIPTAN; TEGASEROD; THIETHYLPERAZINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AGITATION; AMENORRHEA; BRONCHOSPASM; CLINICAL TRIAL; DIAPHORESIS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DROWSINESS; DRUG WITHDRAWAL; DYSTONIA; ENDOSCOPY; FATIGUE; FLUSHING; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; IMPOTENCE; LACRIMATION; MIOSIS; MOTOR DYSFUNCTION; NAUSEA; PARENTERAL NUTRITION; PATHOGENESIS; REVIEW; SALIVATION; SIDE EFFECT; SLEEP DISORDER; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PARESIS; URINARY URGENCY; VOMITING;

ANIMALS; ANTIEMETICS; DIABETES COMPLICATIONS; DIAGNOSTIC IMAGING; ELECTRIC STIMULATION THERAPY; ENDOSCOPY, GASTROINTESTINAL; GASTRECTOMY; GASTRIC BYPASS; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; PROGNOSIS; VAGOTOMY, PROXIMAL GASTRIC;

EID: 35348916785     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.07.004     Document Type: Review

References (128)

1. Hoogerwerf W.A., Pasricha P.J., Kalloo A.N., et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 94 (1999) 1029-1033
2. Soykan I., Sivri B., Saroseik I., et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43 (1998) 2398-2404
3. Bizer E., Harrell S., Koopman J., et al. Obesity is common in gastroparesis despite nausea, vomiting, and early satiety. [abstract]. Gastroenterology 128 (2005) M1895
4. Kong M.F., Horowitz M., Jones K.L., et al. Natural history of diabetic gastroparesis. Diabetes Care 22 (1998) 503-507
5. Bytzer P., Talley N.J., Leemon M., et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus. Arch Intern Med 161 (2001) 1989-1996
6. Horowitz M., Maddox A.F., Wishart J.M., et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 18 (1991) 229-234
7. Horowitz M., Harding P.E., Maddox A.F., et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32 (1989) 151-159
8. Eisenberg B., Murata G.H., Tzamaloukas A.H., et al. Gastroparesis in diabetics on chronic dialysis: clinical and laboratory associations and predictive features. Nephron 70 (1995) 296-300
9. Mearin F., Camilleri M., and Malagelada J.-R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90 (1986) 1919-1925
10. Camilleri M., and Malagelada J.-R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 14 (1984) 420-427
11. Feldman M., Corbett D.B., Ramsey E.J., et al. Abnormal gastric function in longstanding insulin-dependent diabetic patients. Gastroenterology 77 (1979) 12-17
12. Clarke R.J., and Alexander-Williams J. The effect of preserving antral innervation and of a pyloroplasty on gastric emptying after vagotomy in man. Gut 14 (1973) 300-307
13. Kristensson K., Nordborg C., Olsson Y., et al. Changes in the vagus nerve in diabetes mellitus. Acta Pathol Microbiol Scand 79 (1971) 684-685
14. Merio R., Festa A., Bergmann H., et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 20 (1997) 419-423
15. Jones K.L., Russo A., Berry M.K., et al. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 113 (2002) 449-455
16. Ejskjaer N.T., Bradley J.L., Buxton-Thomas M.S., et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 16 (1999) 488-495
17. Forster J., Damjanov I., Lin Z., et al. Absence of interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 9 (2005) 102-108
18. Iwasaki H., Najimura M., Osawa S., et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 41 (2006) 1076-1087
19. Vittal H., Farrugia G., Pehlivanov N.D., et al. Neuropathological and genomic changes in the stomach of patients with human diabetic gastroparesis. [abstract]. Gastroenterology 130 (2006) 245
20. 13C-octanoic acid breath test. J Diabetes Complications 20 (2006) 295-301
21. Barnett J.L., and Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 94 (1988) 739-744
22. Schvarcz E., Palmer M., Aman J., et al. Hypoglycaemia increases the gastric emptying rate in patients with type I diabetes mellitus. Diabet Med 10 (1993) 660-663
23. Samsom M., Vermeijden J.R., Smout A.J., et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care 26 (2003) 3116-3122
24. Jones K.L., Russo A., Stevens J.E., et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 24 (2001) 1264-1269
25. Undeland K.A., Hausken T., Gilja O.H., et al. Gastric meal accommodation studied by ultrasound in diabetes: relation to vagal tone. Scand J Gastroenterol 33 (1998) 236-241
26. Samsom M., Salet G.A., Roelofs J.M., et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 40 (1995) 2037-2042
27. Bityutskiy L.P., Soykan I., and McCallum R.W. Viral gastroparesis: a subgroup of idiopathic gastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol 92 (1997) 1501-1506
28. Sigurdsson L., Flores A., Putnam P.E., et al. Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr 131 (1997) 751-754
29. Lobrano A., Blanchard K., Abell T.L., et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil 18 (2006) 162-167
30. Pande H., Lacy B.E., and Crowell M.D. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci 47 (2002) 2664-2668
31. Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 130 (2006) 1466-1479
32. Abell T.L., Bernstein R.K., Cutts T., et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 18 (2006) 263-283
33. Hasler W., Coleski R., Chey W.D., et al. Selective intragastric pH profile impairment in diabetic vs. idiopathic gastroparesis: relation to degree of gastric stasis. [abstract]. Neurogastroenterol Motil 18 (2006) 741
34. Gaddipati K.V., Simonian H.P., Kresge K.M., et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 51 (2006) 1339-1346
35. Zarate N., Mearin F., Wang X.Y., et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 52 (2003) 966-970
36. Sokol H., Laverge-Slove A., Mikol J., et al. Severe isolated myopathic gastroparesis: a case report with pathological findings. [letter]. Gut 55 (2006) 1662
37. Martin S.T., Collins C.G., Fitzgibbon J., et al. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor?. Eur J Gastroenterol Hepatol 17 (2005) 983-986
38. De Giorgio R., Barbara G., Stanghellini V., et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 12 (2000) 613-616
39. Karamanolis G., Caenepeel P., Arts J., et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?. Gut 56 (2007) 29-36
40. van der Mijle H.C., Kleibeuker J.H., Limburg A.J., et al. Manometric and scintigraphic studies of the relation between motility disturbances in the Roux limb and the Roux-en-Y syndrome. Am J Surg 166 (1993) 11-17
41. Horowitz M., Cook D.J., Collins P.J., et al. Measurement of gastric emptying after gastric bypass surgery using radionuclides. Br J Surg 69 (1982) 655-657
42. Trus T.L., Bax T., Richardson W.S., et al. Complications of laparoscopic paraesophageal hernia repair. J Gastrointest Surg 1 (1997) 221-228
43. Malagelada J.R., Rees W.D., Mazzotta L.J., et al. Gastric motor abnormalities in diabetic and post vagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 78 (1980) 286-293
44. Azpiroz F., and Malagelada J.R. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 92 (1987) 934-943
45. van der Mijle H.C., Beekhuis H., Bleichrodt R.P., et al. Transit disorders of the gastric remnant and Roux limb after Roux-en-Y gastrojejunostomy: relation to symptomatology and vagotomy. Br J Surg 80 (1993) 60-64
46. Tu B.N., and Kelly K.A. Elimination of the Roux stasis syndrome using a new type of "uncut Roux" limb. Am J Surg 170 (1995) 381-386
47. Stanghellini V., and Malagelada J.R. Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication. Gut 24 (1983) 790-797
48. McCallum R.W., Berkowitz D.M., and Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 80 (1981) 285-291
49. Barkin J.S., Goldberg R.I., Sfakianakis G.N., et al. Pancreatic carcinoma is associated with delayed gastric emptying. Dig Dis Sci 31 (1986) 265-267
50. Caras S., Laurie S., Cronk W., et al. Case report: pancreatic cancer presenting with paraneoplastic gastroparesis. Am J Med Sci 312 (1996) 34-36
51. Davies W.T., Kilpatrick J.R., Owen G.M., et al. Gastric emptying in atrophic gastritis and carcinoma of the stomach. Scand J Gastroenterol 6 (1971) 297-301
52. Balaban D.H., Chen J., Lin Z., et al. Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am J Gastroenterol 92 (1997) 519-523
53. Liberski S.M., Koch K.L., Atnip R.G., et al. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 99 (1990) 252-257
54. Maddern G.J., Horowitz M., Jamieson G.G., et al. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 87 (1984) 922-926
55. van der Sijp J.R., Kamm M.A., Nightengale J.M., et al. Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci 38 (1993) 837-844
56. Lennon V.A., Sas D.F., Busk M.F., et al. Enteric neuronal autoantibodies in pseudo-obstruction with small-cell lung carcinoma. Gastroenterology 100 (1991) 137-142
57. Goetze O., Nikodem A.B., Wiezcorek J., et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 18 (2006) 369-375
58. Stacher G., Kiss A., Wiesnagrotzki S., et al. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa. Gut 27 (1986) 1120-1126
59. Rigaud D., Bedig G., Merrouche M., et al. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci 8 (1988) 919-925
60. Amarnath R.P., Abell T.L., and Malagelada J.-R. The rumination syndrome in adults: a characteristic manometric pattern. Ann Intern Med 105 (1986) 513-518
61. Namin F., Jitan P., Joker I., et al. Clinical hallmarks of cyclic vomiting syndrome (CVS) in adults and role of long-term tricyclic therapy. [abstract]. Gastroenterology 130 (2006) T2049
62. Abell T.L., Kim C.H., and Malagelada J.R. Idiopathic cyclic nausea and vomiting: a disorder of gastrointestinal motility?. Mayo Clin Proc 63 (1988) 1169-1175
63. Levy D.M., Williams O.A., Magides A.D., et al. Gastric emptying is delayed at 8-12 weeks' gestation. Br J Anaesth 73 (1994) 237-238
64. Bursztein-De Myttenaere S., Gil K.M., Heymsfield S.B., et al. Gastric emptying in humans: influence of different regimens of parenteral nutrition. Am J Clin Nutr 60 (1994) 244-248
65. Revicki D.A., Rentz A.M., Dubois D., et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 18 (2003) 141-150
66. Rentz A.M., Kahrilas P., Stanghellini V., et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 13 (2004) 1737-1749
67. De Giorgio R., Guerrini S., Barbara G., et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126 (2004) 1872-1883
68. Pasha S.F., Lunsford T.N., and Lennon V.A. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 131 (2006) 1592-1596
69. Parkman H.P., and Schwartz S.S. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med 147 (1987) 1477-1480
70. House A., Champion M.C., and Chamberlain M. National survey of radionuclide gastric emptying studies. Can J Gastroenterol 11 (1997) 317-321
71. Tougas G., Eaker E.Y., Abell T.L., et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 95 (2000) 1456-1462
72. Guo J.P., Maurer A.H., Fisher R.S., et al. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 46 (2001) 24-29
73. Galil M.A., Critchley M., and Mackie C.R. Isotope gastric emptying tests in clinical practice: expectation, outcome, and utility. Gut 34 (1993) 916-919
74. 13C] acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108 (1995) 1048-1055
75. Kuo B., McCallum R.W., Koch K.L., et al. SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease. [abstract]. Gastroenterology 130 (2006) M2205
76. Kuiken S.D., Samsom M., Camilleri M., et al. Development of a test to measure gastric accommodation in humans. Am J Physiol 277 (1999) G1217-G1221
77. Jones K., Edelbroek M., Horowitz M., et al. Evaluation of antral motility in humans using manometry and scintigraphy. Gut 37 (1995) 643-648
78. Soffer E., and Thongsawat S. Clinical value of duodenojejunal manometry: its usefulness in diagnosis and management of patients with gastrointestinal symptoms. Dig Dis Sci 41 (1996) 859-863
79. Chen J.D., Lin Z., Pan J., et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 41 (1996) 1538-1545
80. Koch K.L., Stern R.M., Stewart W.R., et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 84 (1989) 1069-1075
81. Tack J., Caenepeel P., Piessevaux H., et al. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 52 (2003) 1271-1277
82. Benini L., Castellani G., Brighenti F., et al. Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food. Gut 36 (1995) 825-830
83. Sturm A., Holtmann G., Goebell H., et al. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 60 (1999) 422-427
84. McCallum R.W., Valenzuela G., Polepalle S., et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 258 (1991) 136-142
85. Parkman H.P., Hasler W.L., and Fisher R.S. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127 (2004) 1592-1622
86. Ganzini L., Casey D.E., Hoffman W.F., et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 153 (1993) 1469-1475
87. Lin H.C., Sanders S.L., Gu Y.G., et al. Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci 39 (1994) 124-128
88. Stern M.A., and Wolf D.C. Erythromycin as a prokinetic agent: a prospective, randomized, controlled study of efficacy in nasoenteric tube placement. Am J Gastroenterol 89 (1994) 2011-2013
89. Richards R.D., Davenport K., and McCallum R.W. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88 (1993) 203-207
90. Hasler W.L., Heldsinger A., and Owyang C. Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors. Am J Physiol 262 (1992) G50-G55
91. Ray W.A., Murray K.T., Meredith S., et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351 (2004) 1089-1096
92. Soykan I., Sarosiek I., and McCallum R.W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 92 (1997) 976-980
93. Jost W.H. Gastrointestinal motility problems in patients with Parkinson's disease: effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10 (1997) 249-258
94. Degen L., Petrig C., Studer D., et al. Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17 (2005) 821-826
95. Tougas G., Chen Y., Luo D., et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. [abstract]. Gastroenterology 124 (2003) A54
96. McCallum R.W., Fink S.M., Lerner E., et al. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology 84 (1983) 1573-1577
97. Lossos I.S., Mevorach D., and Oren R. Thiethyperazine treatment of gastroparesis diabeticorum. Ann Pharmacother 26 (1992) 1016
98. Prakash C., Lustman P.J., Freedland K.E., et al. Tricyclic antidepressants for functional nausea and vomiting. Dig Dis Sci 43 (1998) 1951-1956
99. Sawhney M.S., Prakash C., Lustman P.J., et al. Tricyclic antidepressants for persistent or recurrent vomiting in diabetic persons. [abstract]. Gastroenterology 120 (2001) A243
100. Kim S.W., Shin I.S., Kim J.M., et al. Mirtazepine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics 47 (2006) 440-442
101. Wang L. Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. J Tradit Chin Med 24 (2004) 163-165
102. Tack J., Piessevaux H., Coulie B., et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115 (1998) 1346-1352
103. Tack J., Caenepeel P., Fischler B., et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121 (2001) 526-535
104. Stacher G., Schernthaner G., Francesconi M., et al. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 84 (1999) 2357-2362
105. Gupta P., and Rao S.S. Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. Gastrointest Endosc 56 (2002) 770-772
106. Lacy B.E., Crowell M.D., Schettler-Duncan A., et al. The treatment of diabetic gastroparesis with botulinum toxin injection into the pylorus. Diabetes Care 27 (2004) 2341-2347
107. Arts J., van Gool S., Caenepeel P., et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 24 (2006) 661-667
108. Bromer M.Q., Friedenberg F., Miller L.S., et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 61 (2005) 833-839
109. Coleski R., and Hasler W. Clinical and gastric functional predictors of symptom response to pyloric injection of botulinum toxin in patients with gastroparesis. [abstract]. Neurogastroenterol Motil 17 (2005) 628
110. Kim C.H., and Nelson D.K. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 47 (1998) 67-70
111. Bilgutay A.M., Wingrove R., Griffin W.O., et al. Gastro-intestinal pacing: a new concept in the treatment of ileus. Ann Surg 158 (1963) 338-348
112. Hocking M.P., Vogel S.B., and Sninsky C.A. Human gastric myoelectric activity and gastric emptying following gastric surgery and with pacing. Gastroenterology 103 (1992) 1811-1816
113. McCallum R.W., Chen J.D., Lin Z., et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 114 (1998) 456-461
114. Abell T.L., Van Cutsem E., Abrahamsson H., et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 66 (2002) 204-212
115. Abell T., McCallum R., Hocking M., et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125 (2003) 421-428
116. Liu J., Qiao X., and Chen J.D. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci 49 (2004) 729-737
117. Xing J.H., Brody F., Brodsky J., et al. Gastric electrical stimulation at proximal stomach induces gastric relaxation in dogs. Neurogastroenterol Motil 15 (2003) 15-23
118. Tack J., Coulie B., Van Cutsem E., et al. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis. [abstract]. Gastroenterology 116 (1999) G4733
119. Weinkauf J.G., Yiannopoulos A., and Faul J.L. Transcutaneous electrical nerve stimulation for severe gastroparesis after lung transplantation. J Heart Lung Transplant 24 (2005) 1444
120. Abouezzi Z.E., Melvin W.S., Ellison E.C., et al. Functional and symptomatic improvement in patients with diabetic gastroparesis following pyloroplasty. [abstract]. Gastroenterology 114 (1998) A1374
121. Eckhauser F.E., Conrad M., Knol J.A., et al. Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg 64 (1998) 711-717
122. Forstner-Barthell A.W., Murr M.M., Nitecki S., et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis. J Gastrointest Surg 3 (1999) 15-21
123. Watkins P.J., Buxton-Thomas M.S., and Howard E.R. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 20 (2003) 58-63
124. Fontana R.J., and Barnett J.L. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 91 (1996) 2174-2178
125. Clouse R.E., and Lustman P.J. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 84 (1989) 868-872
126. Rashed H., Cutts T., Luo J., et al. Predictors of response to a behavioral treatment in patients with chronic gastric motility disorders. Dig Dis Sci 47 (2002) 1020-1026
127. Murray C.D., Martin N.M., Patterson M., et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54 (2005) 1693-1698
128. Dishy V., Cohen Pour M., Feldman L., et al. The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis. Clin Pharmacol Ther 76 (2004) 281-286